E-LIB Suche - Ergebnisse für: Durie, Brian G.

1

Clinical perspectives on the optimal use of lenalidomide pl..:

Richardson, Paul G. ; Durie, Brian G. ; Rosiñol, Laura...
Haematologica. 108 (2023) 11 - p. 2894-2912 , 2023

Link: https://doi.org/10.3324/..

2

Clinical profiles of multiple myeloma in Asia—An Asian Myel..:

Kim, Kihyun ; Lee, Jae Hoon ; Kim, Jin Seok...
American Journal of Hematology. 89 (2014) 7 - p. 751-756 , 2014

Link: https://doi.org/10.1002/..

3

IMMUNOLOGICAL RECONSTITUTION IN SEVERE COMBINED IMMUNODEFIC..:

Sieber, Otto F ; Fulginiti, Vincent A ; Durie, Brian G.
Pediatric Research. 8 (1974) 4 - p. 419-419 , 1974

Link: https://doi.org/10.1203/..

4

SPONTANEOUS EVOLUTION OF IMMUNE COMPETENCE IN DIGEORGE SYND..:

Sieber, Otto F ; Durie, Brian G ; Hattler, Brack G..
Pediatric Research. 8 (1974) 4 - p. 418-418 , 1974

Link: https://doi.org/10.1203/..

5

Prior cancer and risk of monoclonal gammopathy of undetermi..:

Rögnvaldsson, Sæmundur ; Thorsteinsdóttir, Sigrun ; Syriopoulou, Elisavet...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Adjusted Indirect Treatment Comparison of Progression-Free ..:

Durie, Brian G. M. ; Kumar, Shaji K. ; Ammann, Eric M....
Advances in Therapy. 41 (2024) 5 - p. 1923-1937 , 2024

Link: https://doi.org/10.1007/..

7

Disease associations with monoclonal gammopathy of undeterm..:

Sigurbergsdóttir, Aðalbjörg Ýr ; Rögnvaldsson, Sæmundur ; Thorsteinsdóttir, Sigrún...
Haematologica. 108 (2023) 12 - p. 3392-3398 , 2023

Link: https://doi.org/10.3324/..

8

Treatment Patterns, Survival, Quality of Life, and Healthca..:

Lee, Hans C. ; Ramasamy, Karthik ; Weisel, Katja...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 2 - p. 112-122 , 2023

Link: https://doi.org/10.1016/..

9

POSTER: MM-455 Adjusted Indirect Treatment Comparison of Pr..:

Durie, Brian G.M. ; Kumar, Shaji K. ; Ammann, Eric M....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S220 , 2023

Link: https://doi.org/10.1016/..

10

Prevalence of smoldering multiple myeloma based on nationwi..:

Thorsteinsdóttir, Sigrún ; Gíslason, Gauti K. ; Aspelund, Thor...
Nature Medicine. 29 (2023) 2 - p. 467-472 , 2023

Link: https://doi.org/10.1038/..

11

Impact of treatment effect on MRD and PFS: an aggregate dat..:

Paiva, Bruno ; Zherniakova, Anastasiia ; Nuñez-Córdoba, Jorge M....
Blood Advances. 8 (2023) 1 - p. 219-223 , 2023

Link: https://doi.org/10.1182/..

12

Management of multiple myeloma-related renal impairment: re..:

Dimopoulos, Meletios A ; Merlini, Giampaolo ; Bridoux, Frank...
The Lancet Oncology. 24 (2023) 7 - p. e293-e311 , 2023

Link: https://doi.org/10.1016/..

13

Author Correction: Prevalence of smoldering multiple myelom..:

Thorsteinsdóttir, Sigrún ; Gíslason, Gauti K. ; Aspelund, Thor...
Nature Medicine. 29 (2023) 12 - p. 3269-3269 , 2023

Link: https://doi.org/10.1038/..

14

MM-455 Adjusted Indirect Treatment Comparison of Progressio..:

Durie, Brian G.M. ; Kumar, Shaji K. ; Ammann, Eric M....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S500 , 2023

Link: https://doi.org/10.1016/..

15

Determining hemodilution in diagnostic bone marrow aspirate..:

Óskarsson, Jón Þórir ; Rögnvaldsson, Sæmundur ; Thorsteinsdottir, Sigrun...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..